Bernd Schnabl MD
Professor of Medicine, Department of Medicine, University of California San Diego, La Jolla, CaliforniaDr. Schnabl is a trained gastroenterologist and physician-scientist. He received his MD degree from the University Freiburg in Germany. After finishing his residency in internal medicine, he completed a gastroenterology fellowship at Columbia University in New York City. He joined the Division of Gastroenterology at UC San Diego in 2008 and he is currently Professor of Medicine. He is staff physician and attending at the VA San Diego Medical Center in La Jolla and the UCSD Medical Center. He is the Director of the NIH-funded San Diego Digestive Diseases Research Center (SDDRC). His research focus is to understand the complex multi-directional interactions that occur between the gut microbiota and the liver.
Disclosures
Bernd Schnabl has consulted for Ferring Research Institute, HOST Therabiomics, Intercept Pharmaceuticals, Mabwell Therapeutics, Patara Pharmaceuticals, Surrozen, and Takeda. Dr. Schnabl's institution, UC San Diego, has received research support from Axial Biotherapeutics, BiomX, ChromoLogic, CymaBay Therapeutics, NGM Biopharmaceuticals, Prodigy Biotech, and Synlogic Operating Company. Dr. Schnabl is founder of Nterica Bio. UC San Diego has filed several patents with Dr. Schnabl as inventor.